Skip to content
Disclosery

Artal Group S.A.

Follow

13F filer, CIK 1053906, LUXEMBOURG, Luxembourg

Artal Group S.A. reported $758,221,325 across 2 holdings for the quarter ended 2025-09-30, in a 13F-HR filed 2025-11-12.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001053906-25-000012

Period
2025-09-30
Reported value
$758M
Holdings
2
Top 10 weight
100%
New
0
Sold out
0

Part of the filer group Artal Group S.A.

How groups are built

Holdings, Q3 2025

Share positions as resolved from 13F-HR 0001053906-25-000012, largest first. % of portfolio is the value over $758,221,325, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
CAVACAVA GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 17,507,990 shares; 2024Q4: 9,507,990 shares; 2025Q1: 9,507,990 shares; 2025Q2: 9,507,990 shares; 2025Q3: 9,507,990 shares 9,507,990$574M75.75%0Timeline
LXRXLEXICON PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 136,180,481 shares; 2024Q4: 136,180,481 shares; 2025Q1: 136,180,481 shares; 2025Q2: 136,180,481 shares; 2025Q3: 136,180,481 shares 136,180,481$184M24.25%0Timeline

How Q3 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001053906-25-000012 base2025-11-12acceptance time not in the bulk data set